#USA #Los Angeles #Partillion #Nanovials #Developer Kits

Partillion Bioscience Launches Developer Kits: Empowering Innovation with Nanovials

Partillion Bioscience has taken a significant step forward in the field of life sciences with the launch of its Developer Kits, designed to provide robust foundations for teams utilizing Nanovials to create tailored assays and workflows. This breakthrough was announced on November 3, 2025, amid growing excitement in the research community about the potential applications of Nanovials.

The Developer Kits offer researchers a streamlined way to connect their innovative concepts to functional data. By integrating Nanovials with validated capture antibodies and standardized reagents, these kits significantly reduce the time and effort needed for early optimization. As Joe de Rutte, CEO and Co-Founder of Partillion, stated, "Our customers are constantly expanding what's possible with Nanovials... Developer Kits combine the best of both worlds—the performance of a purpose-built kit and the freedom of an open platform."

Over the years, Partillion's Nanovials have established a reputation as a reliable platform for researchers pursuing dynamic cellular function analysis, especially in the realm of single-cell and multicell assays. As the scientific community veers toward spatial biology, there’s a concerted effort to look beyond static representations and delve deeper into cell–cell interactions and multicellular functions. This marks a pivotal evolution in understanding biology on a broader scale. The Developer Kits serve to further solidify this transition, empowering researchers to bring innovative concepts to life more effectively than ever before.

These kits have been developed with the foresight of the Billion Cell × Cell Project, which aims to map and quantify functional interactions across one billion cells. The Developer Kits offer ready-to-use protocols and reagents, thus bridging the gap between theoretical exploration and practical application, essentially allowing researchers to connect spatial contexts with functional outcomes.

"We've always believed in an open, flexible platform," de Rutte added. The Developer Kits extend that philosophy, providing researchers with the chance to harness the performance and reliability of Nanovials, while maintaining the creative freedom necessary for scientific discovery.

Researchers utilizing Partillion's Developer Kits can choose from two different Nanovial sizes, catering to either single-cell or multicell assays. Moreover, a selection of capture antibodies is available tailored for various applications, including immunology, antibody discovery, cell therapy development, synthetic biology, and aging research. The company is committed to supporting its users by providing detailed documentation that guides teams in designing and optimizing their own assays.

Currently, the Developer Kits are available for purchase, and Partillion anticipates expanding the range of available antibodies shortly. For more information on the Developer Kits, interested parties can visit Partillion's official site.

About Partillion Bioscience

Partillion Bioscience is at the forefront of functional cell analysis technology, boasting an innovative platform built upon its award-winning Nanovial technology. The company's dedication enables pharmaceutical and biotechnology partners to expedite therapeutic development by facilitating the screening of millions of live cells simultaneously, capturing vital functional metrics like secretion, signaling, and viability.

With features in prestigious publications—including Nature Nanotechnology, Nature Communications, and Science Advances—Partillion's groundbreaking technology has garnered several accolades, including the 2020 SLAS Innovation Award and the 2025 CYTO Innovation Technology Showcase Award. Discover more about their offerings and innovative approaches on their website at www.partillion.com.